Notice2024-00753
National Cancer Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
January 17, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 11 (Wednesday, January 17, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 11 (Wednesday, January 17, 2024)]
[Notices]
[Pages 2964-2965]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-00753]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications/contract
proposals, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel TEP-8: SBIR Contract Review.
Date: February 14, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute, Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#7b080e081a1555080b1e15181e3b151213551c140d"><span class="__cf_email__" data-cfemail="cfbcbabcaea1e1bcbfaaa1acaa8fa1a6a7e1a8a0b9">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-6A: SBIR Contract Review.
Date: February 22-23, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#7704020416195904071219141237191e1f59101801"><span class="__cf_email__" data-cfemail="10636563717e3e6360757e7375507e79783e777f66">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Human Tumor Atlas (HTA) Research Centers (U01).
Date: February 29, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W240, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Hasan Siddiqui, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W240, Rockville, Maryland 20850, 240-276-5122,
<a href="/cdn-cgi/l/email-protection#0961687a6867277a606d6d60787c6049676061276e667f"><span class="__cf_email__" data-cfemail="8ce4edffede2a2ffe5e8e8e5fdf9e5cce2e5e4a2ebe3fa">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; TEP-6B: SBIR Contract Review.
Date: March 1, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#54272127353a7a2724313a3731143a3d3c7a333b22"><span class="__cf_email__" data-cfemail="65161016040b4b1615000b0600250b0c0d4b020a13">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP 11: NCI Clinical and Translational Cancer Research.
Date: March 7, 2024.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W602, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Delia Tang, M.D., Scientific Review Officer,
Resources and Training Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W602, Rockville, Maryland 20850, 240-276-6456,
<a href="/cdn-cgi/l/email-protection#1d697c737a795d707c747133737475337a726b"><span class="__cf_email__" data-cfemail="1c687d727b785c717d757032727574327b736a">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Translational Research Toward Development of a Kaposi Sarcoma
Herpesvirus (KSHV) Vaccine (U01).
Date: March 12, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W264, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Ombretta Salvucci, Ph.D., Scientific Review
Officer, Special Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W264, Rockville, Maryland 20850, 240-276-7286,
<a href="/cdn-cgi/l/email-protection#2b584a475d5e4848446b464a424705454243054c445d"><span class="__cf_email__" data-cfemail="ef9c8e83999a8c8c80af828e8683c1818687c1888099">[email protected]</span></a>.
[[Page 2965]]
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Research Project-Cooperative Agreements (U01).
Date: March 13, 2024.
Time: 9:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W244, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Amr M. Ghaleb, Ph.D., Scientific Review Officer,
Research Program Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W244, Rockville, Maryland 20850, 240-276-6611, <a href="/cdn-cgi/l/email-protection#4f2e223d6128272e232a2d0f21262761282039"><span class="__cf_email__" data-cfemail="3c5d514e125b545d50595e7c525554125b534a">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; The role of Epstein Barr virus (EBV) infection in Non-Hodgkin
Lymphoma (NHL) and Hodgkin disease (HD) development with or without
an underlying HIV infection.
Date: March 13, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W634, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Michael E. Lindquist, Ph.D., Scientific Review
Officer, Research Programs Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W634, Rockville, Maryland 20850,
<a href="/cdn-cgi/l/email-protection#bad7d3d1df94d6d3d4decbcfd3c9cefad4d3d294ddd5cc"><span class="__cf_email__" data-cfemail="dbb6b2b0bef5b7b2b5bfaaaeb2a8af9bb5b2b3f5bcb4ad">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Early-Stage Development of Informatics Technologies for
Cancer Research and Management (U01 Clinical Trial Optional).
Date: March 13-14, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Susan Lynn Spence, Ph.D., Scientific Review
Officer, Research Technology and Contract Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Rockville, Maryland 20850, 240-620-0819,
<a href="/cdn-cgi/l/email-protection#ee9d9b9d8f80c09d9e8b808d8bae808786c0898198"><span class="__cf_email__" data-cfemail="d8abadabb9b6f6aba8bdb6bbbd98b6b1b0f6bfb7ae">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI SEP: Health Disparities in Underrepresented People Living
with HIV and Cancer.
Date: March 14, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W618, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: E. Tian, Ph.D., Scientific Review Officer,
Research Program Review Branch, Division of Extramural Activities,
National Cancer Institute, NIH, 9609 Medical Center Drive, Room
7W618, Rockville, Maryland 20850, 240-276-6611, <a href="/cdn-cgi/l/email-protection#196d7078777c597478707537777071377e766f"><span class="__cf_email__" data-cfemail="7b0f121a151e3b161a121755151213551c140d">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Pre-Cancer Atlas Research Centers (RFA-CA-23-040) and Human
Tumor Atlas Network Data Coordinating Center (RFA-CA-23-041).
Date: March 21, 2024.
Time: 10:00 a.m. to 5:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute at Shady Grove, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Byeong-Chel Lee, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W238, Rockville, Maryland 20850, 240-276-7755,
<a href="/cdn-cgi/l/email-protection#6d0f140802030a400e050801430108082d030405430a021b"><span class="__cf_email__" data-cfemail="1a78637f75747d3779727f7634767f7f5a747372347d756c">[email protected]</span></a>.
Name of Committee: National Cancer Institute Special Emphasis
Panel; SEP-2: NCI Clinical and Translational Cancer Research.
Date: March 21, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W108, Rockville, Maryland 20850 (Virtual
Meeting).
Contact Person: Clifford W. Schweinfest, Ph.D., Scientific
Review Officer, Special Review Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Rockville, Maryland 20850, 240-276-6343,
<a href="/cdn-cgi/l/email-protection#314252594654585f575442455246715c50585d1f5f58591f565e47"><span class="__cf_email__" data-cfemail="d0a3b3b8a7b5b9beb6b5a3a4b3a790bdb1b9bcfebeb9b8feb7bfa6">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: January 11, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-00753 Filed 1-16-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on January 17, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.